BMJ  2008;336:418-419 (23 February), doi:10.1136/bmj.39491.469005.94

Feature

Drug Research

Balancing Big Pharma’s books

Andrew Jack, pharmaceuticals correspondent

1 Financial Times, London

Andrew.Jack@ft.com

With patents running out on their big earning products and recent scandals undermining their image, drug companies are under pressure. Andrew Jack reports on their problems

The first 150 words of the full text of this article appear below.

When business chief executives joined politicians and public officials gathered at the World Economic Forum in Davos last month, one group of industry leaders was noticeably under-represented: those from the pharmaceutical sector. Some regulars in previous years, such as Hank McKinnell, the outspoken former head of Pfizer, the world’s largest drug group, have lost their jobs. Others, like Richard Clark from Merck and Daniel Vasella from Novartis, pulled out at the last minute. The message was clear. At a time of investor dissatisfaction with their companies and employee disgruntlement at cutbacks, they would do better to stay in their headquarters and focus on internal problems rather than debate the broader issues of the world.

To many, it seems hard to believe that the drug industry - long spoilt by lavish revenues and little need for controls on spending - is in crisis. In fact, its current malaise is characterised by . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Patients and the public deserve big changes in evaluation of drugs
Silvio Garattini and Iain Chalmers
BMJ 2009 338: b1025. [Extract] [Full Text]

This article has been cited by other articles:

  • Garattini, S., Chalmers, I. (2009). Patients and the public deserve big changes in evaluation of drugs. BMJ 338: b1025-b1025 [Full text]  

Rapid Responses:

Read all Rapid Responses

Trouble ahead for "Big Pharma"
Manthan D. Janodia, et al.
bmj.com, 24 Feb 2008 [Full text]
There is no right answer to the wrong question
Aubrey Blumsohn
bmj.com, 27 Feb 2008 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ